Search Results

Site Search

Alpha-gal testing [Test in Focus] - Insights

Joshua Bornhorst, Ph.D., associate director of Mayo Clinic's Clinical Immunoassay Lab, explains how humans can develop an allergy to the alpha-gal molecule, and he describes a new allergen antibody test that can be used to detect it. Dr....

MDM2 gene amplification [Test in Focus] - Insights

William Sukov, M.D., provides an overview of the MDM2 gene amplification assay — a test that looks for amplification of the MDM2 gene region on chromosome 12q. He reviews when this test should be ordered, how it compares to other test...

Plasma Cell Proliferative Disorder [Test in Focus] - Insights

Linda Baughn Ph.D. gives an overview of this new test available through Mayo Clinic Laboratories. She discusses when this testing should be ordered, how this testing improves upon other testing approaches, and what clinical action can be...

B-cell lymphoblastic leukemia monitoring for minimal residual disease [Test in Focus] - Insights

Min Shi, M.D., Ph.D., a hematologist and co-director of Mayo Clinic's Flow Cytometry Laboratory, explains recent updates to the B-cell lymphoblastic leukemia minimal residual disease flow cytometry assay. This test is used to identify...

Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) calculator - Insights

For guidance on when to use the calculator, please see the following algorithm: Acquired Neuropathy Diagnostic Algorithm.

New tests launched in September - Insights

In September 2021, Mayo Clinic Laboratories announced seven new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

Independence Day Specimen Shipment Alert - Insights

Due to the Independence Day holiday, Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered. To ensure that your specimen vitality and turnaround times are not affected, plan ahead.

Study Shows Drug Reduces Risk of Relapse with Neuromyelitis Optica - Insights

"This study offers hope to patients, since each attack in NMO can cause loss of visual or motor function," says Sean Pittock, M.D., a Mayo Clinic neurologist and first author.

Independence Day Specimen Shipment Alert - Insights

Due to the Independence Day holiday, Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered. To ensure that your specimen vitality and turnaround times are not affected, plan ahead.

Mayo Clinic, Thermo Fisher Scientific collaborate to benefit patients - Insights

Mayo Clinic and Thermo Fisher have joined forces to bring innovative solutions to patients.

Memorial Day Specimen Shipment Alert - Insights

Due to the Memorial Day holiday (recognized on Monday, May 30), Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered. To ensure that your specimen vitality and turnaround times are not affected, please plan...

Memorial Day Specimen Shipment Alert - Insights

Due to the Memorial Day holiday (recognized on Monday, May 31), Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered. To ensure that your specimen vitality and turnaround times are not affected, plan ahead and...

Darci Block, Ph.D., discusses saliva testing in AACC's Clinical Laboratory News - Insights

Saliva testing has emerged as a viable option for obtaining rapid, reliable test results during the COVID-19 pandemic. Mayo Clinic’s Dr. Darci Block considers how this type of testing may expand beyond the pandemic, and the obstacles in its...

Advanced Biological Laboratories, Mayo Clinic Laboratories Collaborate on Test Development to Help Patients with Cytomegalovirus Infection - Insights

Advanced Biological Laboratories (ABL), S.A., a Luxembourg-based diagnostics company and leader in virology genotyping, and Mayo Clinic Laboratories have announced a collaboration. The two organizations are working together to develop a...

Autoimmune evolution - Insights

Mayo Clinic Laboratories is leading an evolution in autoimmune neurology diagnosis. To better reflect this testing evolution, and to reduce confusion and improve utilization for our clients, effective April 28, we are renaming our...

CPT codes and LOINC update: August 2022 - Insights

This list includes updates posted to mayocliniclabs.com during the month of August.

Tips & Tricks for Difficult Sticks - Insights

This "Phlebotomy webinar" focuses on the origins of difficult collections and the situations that result in them.

Copeptin [Test in Focus] - Insights

Joshua Bornhorst, Ph.D., gives an overview of the new Copeptin test available through Mayo Clinic Laboratories. He discusses when this testing should be ordered, how this testing improves upon previous testing approaches, and what clinical...

Practical aspects & pitfalls in molecular diagnosis of brain tumors - Insights

This "Specialty Testing" webinar will address practical aspects and pitfalls in the molecular diagnosis of brain tumors.

Blood Diversion/Culture Contamination - Insights

PACE / State of FLThis “phlebotomy webinar” will address the evidence behind blood diversion as a mechanism to lower blood culture contamination rates and discuss the experience at Mayo Clinic Rochester with a pilot of one blood diversion...

Autoimmune Myelopathy Evaluation [Test in Focus] - Insights

Patients with autoimmune myelopathy present with subacute onset and rapid progression of spinal cord symptoms (weakness, gait difficulties, loss of sensation, neuropathic pain, and bowel and bladder dysfunction). Autoimmune myelopathy...

Orexin-A/Hypocretin-1 for the Diagnosis of Type 1 Narcolepsy [Test in Focus] - Insights

The standard test for the diagnosis of narcolepsy is the multiple sleep latency test (MSLT). The MSLT is a complex test to perform as well as to interpret. The orexin-A/hypocretin-1 test is a sensitive and specific alternative to the MSLT...

Holiday Specimen Shipment - Insights

Due to the Independence Day holiday (recognized on Saturday, July 4), Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered.

Pediatric CNS Disorder Evaluations [Test in Focus] - Insights

Autoimmune encephalitis and myelitis is increasingly recognized as a cause of CNS disease in children and teens. Andrew McKeon, M.B., B.Ch., M.D, gives an overview of this test available through Mayo Clinic Laboratories. He discusses when...

CPT codes and LOINC update: November 2020 - Insights

The following list includes updates posted to mayocliniclabs.com during the month of November

Osmotic fragility testing - Insights

In this month’s “Hot Topic,” James Hoyer, M.D., discusses the importance of using a control tube during osmotic fragility testing.

Phlebotomy Modules: Module 3 | Insights

Skip to Content MayoACCESS MayoLINK...

Phlebotomy Modules: Module 1 | Insights

Skip to Content MayoACCESS MayoLINK...

Phlebotomy Modules: Module 3 | Insights

Skip to Content MayoACCESS MayoLINK...

Phlebotomy Modules: Module 2 | Insights

Skip to Content MayoACCESS MayoLINK...

Phlebotomy Modules: Module 1 | Insights

Skip to Content MayoACCESS MayoLINK...

New tests launched in April - Insights

In April 2022, Mayo Clinic Laboratories announced fourteen new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

Autoimmune Gastrointestinal Dysmotility Evaluation [Test in Focus] - Insights

Divyanshu (Div), Dubey, M.B.B.S, gives an overview of the new Autoimmune Gastrointestinal Dysmotility Evaluation available through Mayo Clinic Laboratories. He discusses when this testing should be ordered, how this testing compares to...

Urinary Steroid Profile [Test in Focus] - Insights

Irina Bancos, M.D. gives an overview of this test available through Mayo Clinic Laboratories. She discusses when this testing should be ordered, how this testing compares to other testing approaches, and what clinical action can be taken...

Christmas and New Year's specimen shipment alert - Insights

Due to the Christmas and New Year's holiday's (recognized on Saturday, December 25th, and Saturday, January 1st ), Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered. To ensure that your specimen vitality and...

Jason Hipp, M.D., Ph.D., named chair of DLMP's new Division of Clinical Informatics - Insights

Dr. Hipp is a board-certified pathologist with fellowship training in pathology informatics, as well as artificial intelligence, machine, and deep-learning experience.

Hepatitis C Virus Genotypic Antiviral Drug Resistance [Test in Focus] - Insights

Joseph Yao, M.D., gives an overview of this new test available through Mayo Clinic Laboratories. He discusses when this testing should be ordered, how this testing improves upon other testing approaches, and what clinical action can be...

Gastrointestinal Pathogen Panel, PCR, Feces [Test in Focus] - Insights

The new Gastrointestinal Pathogen Panel, PCR, Feces test is now available to the Mayo Clinic practice and Mayo Medical Laboratories clients.

Testing to Identify Clinically Significant Chromosomal Abnormalities - Insights

This week's featured chromosomal microarray test in focus is presented by William Sukov, M.D., a pathologist and cancer geneticist at Mayo Clinic. He discusses when this test should be used for patients with renal tumors.

Psychotropic PGx Panel for Drug Treatment Optimization [Test in Focus] - Insights

Ann Moyer, M.D., Ph.D. gives an overview of this new test available through Mayo Clinic Laboratories. She discusses when this testing should be ordered, how this testing improves upon other testing approaches, and what clinical action can...

Mayo Clinic Laboratory and pathology research roundup: March 15 - Insights

This Feature Includes: Assessing the contribution of rare variants to complex trait heritability from whole-genome sequence data.

New Test Options for NTRK Gene Fusions - Insights

The presence NTRK gene fusions is one of the eligibility requirements for the recently FDA-approved therapy Vitrakvi (larotrectinib), a therapy indicated in adult and pediatric patients with solid tumors regardless of the type of tumor....

Molecular Detection for Tuberculosis Drug Resistance [Test in Focus] - Insights

Nancy Wengenack, Ph.D. gives an overview of this test available through Mayo Clinic Laboratories. She discusses when this testing should be ordered, how this testing compares to other testing approaches, and what clinical action can be...

The Prostate Health Index (PHI) in Prostate Cancer Risk Assessment - Insights

In this month’s “Hot Topic,” Alicia Algeciras-Schimnich, Ph.D., will provide you with valuable information regarding the utility of the prostate specific antigen test, and how the calculation of a prostate health index, or phi, can help to...

New High-Resolution Targeted Opioid Screen: Superior Sensitivity and Specificity to Evaluate Adherence to Prescribed Opioid Therapy - Insights

In this month’s “Hot Topic,” Paul Jannetto, Ph.D., discusses the high-resolution targeted opioid screening test from Mayo Clinic Laboratories, which offers sensitivity and specificity for use in the monitoring and management of patients who...

January 2022 - Cardiovascular Pathology - Insights

This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Cardiovascular Pathology.

https://news.mayocliniclabs.com/file-ai-antibody-matrix/

The evolution of phenotype-specific antibody testing Autoimmune neurology testing is rapidly evolving, with increasing numbers of clinically relevant biomarkers discovered each year. Mayo Clinic’s Neuroimmunology Laboratory has developed...

Own your lab, own your future - Insights

The laboratory is the cornerstone for health systems that offer complex care. Learn how lab ownership is a key driver of patient care excellence and health system growth.

New tests launched in November - Insights

In November 2022, Mayo Clinic Laboratories announced eighteen new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

Updated testing algorithms for plasma cell proliferative disorders [Test in Focus] - Insights

Xinjie Xu, Ph.D., co-director of Mayo's Genetics and Genomics Laboratory, explains Mayo Clinic Laboratories' updated approach to testing for risk stratification of patients newly diagnosed with plasma cell proliferative disorders, such as...